Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4551
iShares MSCI Malaysia ETF
EWM
$284M
| $60.9K | ﹤0.01% |
2,500
| – | – |
2022 Q1
13 quarters
|
|
|
DBVT
4552
DBV Technologies S.A. American Depositary Shares
DBVT
$663M
| $60.6K | ﹤0.01% |
6,611
+6,313
| +2,118% | +$55.8K |
2022 Q2
12 quarters
|
|
4553
State Street SPDR S&P Pharmaceuticals ETF
XPH
$525M
| $60.5K | ﹤0.01% |
+1,491
| New | +$59.9K |
2025 Q2
0 quarters
|
|
4554
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$161B
| $60.4K | ﹤0.01% |
4,000
| – | – |
2023 Q3
7 quarters
|
|
|
GREK
4555
Global X MSCI Greece ETF
GREK
$332M
| $60.3K | ﹤0.01% |
1,039
| – | – |
2022 Q1
13 quarters
|
|
4556
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
| $60.3K | ﹤0.01% |
25,000
-13,221
| -35% | -$32.5K |
2022 Q1
13 quarters
|
|
4557
Innovator US Equity Accelerated 9 Buffer ETF January
XBJA
$93.9M
| $58.8K | ﹤0.01% |
1,950
-3,064
| -61% | -$87.7K |
2024 Q3
3 quarters
|
|
4558
iShares Asia 50 ETF
AIA
$5.01B
| $58.8K | ﹤0.01% |
725
| – | – |
2020 Q1
21 quarters
|
|
4559
Innovator Uncapped Accelerated US Equity ETF
XUSP
$52.7M
| $58.6K | ﹤0.01% |
1,394
-3,401
| -71% | -$130K |
2025 Q1
1 quarter
|
|
4560
Ocugen
OCGN
$346M
| $58.6K | ﹤0.01% |
60,400
-253,888
| -81% | -$211K |
2024 Q2
4 quarters
|
|
4561
Vera Bradley
VRA
$147M
| $57.9K | ﹤0.01% |
26,202
-24,253
| -48% | -$50K |
2022 Q3
11 quarters
|
|
|
QIPT
4562
DELISTED
Quipt Home Medical
QIPT
| $57.6K | ﹤0.01% |
32,168
-37,761
| -54% | -$74.5K |
2023 Q1
9 quarters
|
|
4563
iShares MSCI Turkey ETF
TUR
$170M
| $57K | ﹤0.01% |
1,766
+1,500
| +564% | +$47.1K |
2013 Q2
48 quarters
|
|
4564
VanEck Morningstar Wide Moat ETF
MOAT
$11.3B
| $56.8K | ﹤0.01% |
606
| – | – |
2023 Q2
8 quarters
|
|
|
KG
4565
Kestrel Group
KG
$41M
| $56.6K | ﹤0.01% |
2,133
-2,371
| -53% | -$54.8K |
2023 Q2
8 quarters
|
|
4566
iShares MSCI EAFE Value ETF
EFV
$30.5B
| $56.5K | ﹤0.01% |
890
-1,725
| -66% | -$106K |
2022 Q4
10 quarters
|
|
|
HEAL
4567
Global X Funds Global X HealthTech ETF
HEAL
$30.3M
| $56.3K | ﹤0.01% |
1,721
| – | – |
2023 Q2
8 quarters
|
|
|
FOXX
4568
Foxx Development Holdings
FOXX
$18.4M
| $55.6K | ﹤0.01% |
10,130
+8,700
| +608% | +$46.4K |
2025 Q1
1 quarter
|
|
4569
Cognyte Software
CGNT
$645M
| $55.6K | ﹤0.01% |
6,017
+2,382
| +66% | +$23.4K |
2022 Q1
13 quarters
|
|
|
MARU
4570
AllianzIM U.S. Equity Buffer15 Uncapped Mar ETF
MARU
$35.5M
| $55.2K | ﹤0.01% |
+2,144
| New | +$52.4K |
2025 Q2
0 quarters
|
|
4571
Vroom Inc
VRM
$47.3M
| $55.1K | ﹤0.01% |
+1,934
| New | +$58.9K |
2025 Q2
0 quarters
|
|
4572
Stem
STEM
$41M
| $53.5K | ﹤0.01% |
8,589
-642
| -7% | -$5.76K |
2022 Q1
13 quarters
|
|
4573
Value Line
VALU
$380M
| $52.8K | ﹤0.01% |
1,349
+494
| +58% | +$19.3K |
2019 Q1
25 quarters
|
|
4574
Innovator US Equity Power Buffer ETF December
PDEC
$993M
| $52.8K | ﹤0.01% |
1,320
+1,167
| +763% | +$44.5K |
2025 Q1
1 quarter
|
|
4575
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $52.3K | ﹤0.01% |
1,422
+1,307
| +1,137% | +$45.9K |
2025 Q1
1 quarter
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.